Market Closed -
Nyse
04:00:02 2024-05-17 pm EDT
|
5-day change
|
1st Jan Change
|
8.9
USD
|
+0.11%
|
|
+0.11%
|
-19.82%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
567.2
|
629.3
|
1,140
|
621.1
|
727.8
|
583.7
|
-
|
-
|
Enterprise Value (EV)
1 |
567.2
|
1,210
|
1,704
|
621.1
|
727.8
|
1,229
|
1,214
|
1,203
|
P/E ratio
|
132
x
|
-76.8
x
|
93.4
x
|
47.4
x
|
48.3
x
|
396
x
|
141
x
|
223
x
|
Yield
|
6.05%
|
6.13%
|
4.62%
|
8.86%
|
-
|
9.44%
|
9.61%
|
10%
|
Capitalization / Revenue
|
8.02
x
|
6.71
x
|
9.83
x
|
4.52
x
|
5.16
x
|
4.2
x
|
4.07
x
|
3.97
x
|
EV / Revenue
|
8.02
x
|
12.9
x
|
14.7
x
|
4.52
x
|
5.16
x
|
8.84
x
|
8.47
x
|
8.18
x
|
EV / EBITDA
|
11
x
|
23
x
|
20.3
x
|
6.52
x
|
7.64
x
|
13.1
x
|
11.7
x
|
10.4
x
|
EV / FCF
|
-
|
-6,608,668
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
42,872
|
48,188
|
64,208
|
65,518
|
65,565
|
65,588
|
-
|
-
|
Reference price
2 |
13.23
|
13.06
|
17.75
|
9.480
|
11.10
|
8.900
|
8.900
|
8.900
|
Announcement Date
|
3/4/20
|
3/3/21
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
70.73
|
93.73
|
115.9
|
137.3
|
141
|
138.9
|
143.3
|
147.1
|
EBITDA
1 |
51.7
|
52.53
|
84
|
95.2
|
95.2
|
94.07
|
103.3
|
115.9
|
EBIT
1 |
27.06
|
16.18
|
37.12
|
38.47
|
37.07
|
34.83
|
-
|
-
|
Operating Margin
|
38.26%
|
17.26%
|
32.02%
|
28.02%
|
26.28%
|
25.07%
|
-
|
-
|
Earnings before Tax (EBT)
|
9.588
|
-2.499
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
3.412
|
-7.747
|
11.8
|
13.32
|
14.79
|
0.2522
|
3.837
|
3.243
|
Net margin
|
4.82%
|
-8.27%
|
10.18%
|
9.7%
|
10.49%
|
0.18%
|
2.68%
|
2.2%
|
EPS
2 |
0.1000
|
-0.1700
|
0.1900
|
0.2000
|
0.2300
|
0.0225
|
0.0633
|
0.0400
|
Free Cash Flow
|
-
|
-183.2
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-195.41%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.8000
|
0.8000
|
0.8200
|
0.8400
|
-
|
0.8400
|
0.8550
|
0.8933
|
Announcement Date
|
3/4/20
|
3/3/21
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
30.34
|
31.88
|
33.7
|
35.41
|
36.31
|
36.23
|
36.35
|
35.51
|
32.96
|
35.12
|
34.33
|
34.68
|
35.13
|
35.66
|
35.94
|
EBITDA
1 |
21.88
|
22.27
|
23.27
|
24.65
|
25
|
24.85
|
24.66
|
23.91
|
21.78
|
23.29
|
24.32
|
24.23
|
24.54
|
25.17
|
25.59
|
EBIT
1 |
9.232
|
9.087
|
9.235
|
10.24
|
9.912
|
9.959
|
9.859
|
9.714
|
7.535
|
9.204
|
8.65
|
8.611
|
8.362
|
-
|
-
|
Operating Margin
|
30.42%
|
28.51%
|
27.41%
|
28.92%
|
27.3%
|
27.49%
|
27.12%
|
27.36%
|
22.86%
|
26.21%
|
25.2%
|
24.83%
|
23.8%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
4.286
|
3.834
|
10.03
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
3.804
|
2.661
|
2.236
|
8.057
|
0.369
|
0.673
|
11.82
|
3.138
|
-0.84
|
0.794
|
-0.1495
|
-0.008
|
0.1254
|
0.3672
|
0.684
|
Net margin
|
12.54%
|
8.35%
|
6.64%
|
22.76%
|
1.02%
|
1.86%
|
32.52%
|
8.84%
|
-2.55%
|
2.26%
|
-0.44%
|
-0.02%
|
0.36%
|
1.03%
|
1.9%
|
EPS
2 |
0.0600
|
0.0400
|
0.0300
|
0.1200
|
0.0100
|
0.0100
|
0.1800
|
0.0500
|
-0.0100
|
0.0100
|
-0.005000
|
0.005000
|
0.005000
|
0.0100
|
0.0100
|
Dividend per Share
2 |
0.2050
|
0.2100
|
0.2100
|
0.2100
|
0.2100
|
0.2100
|
0.2100
|
0.2100
|
-
|
-
|
0.2100
|
0.2100
|
0.2100
|
0.2150
|
0.2150
|
Announcement Date
|
2/28/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/28/23
|
5/3/23
|
8/2/23
|
11/6/23
|
2/27/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
581
|
565
|
-
|
-
|
645
|
630
|
619
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
11.06
x
|
6.721
x
|
-
|
-
|
6.857
x
|
6.099
x
|
5.34
x
|
Free Cash Flow
|
-
|
-183
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/4/20
|
3/3/21
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Average target price
10.38
USD Spread / Average Target +16.57% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.82% | 584M | | +12.32% | 60.56B | | -1.87% | 19.76B | | +0.45% | 14B | | -0.10% | 7.57B | | -7.89% | 6.01B | | +12.06% | 3.56B | | +0.46% | 3.32B | | -4.32% | 3.15B | | +2.04% | 3.01B |
Healthcare REITs
|